Unknown

Dataset Information

0

Non-Carriers of Reduced-Function CYP2C19 Alleles are Most Susceptible to Impairment of the Anti-Platelet Effect of Clopidogrel by Proton-Pump Inhibitors: A Pilot Study.


ABSTRACT: BACKGROUND:The phenomenon of CYP2C19 polymorphism affects the metabolism of both clopidogrel and proton-pump inhibitors (PPI). However, concomitant use of both drugs may reduce the desired therapeutic effects. In this study, we evaluated whether individuals with different numbers of reduced-function CYP2C19 alleles were equally affected and whether PPIs with different dependencies on CYP2C19 metabolism were equally involved. METHODS:Thirty healthy volunteers were recruited to a six-week regimen of clopidogrel. Three PPIs with different metabolic dependencies on CYP2C19 were included and separately administered in this order. Each PPI was given for a week, followed by a one-week washout period before the intervention of the next PPI. The anti-platelet effect was examined by Thromboelastography Platelet Mapping(TM) (TEG®) and vasodilator-stimulated phosphoprotein (VASP) assays. RESULTS:Both TEG® and VASP tests showed the same general qualitative trend, but TEG® detected a statistically significant fluctuation of platelet aggregation in response to different drug interventions. The TEG® results also demonstrated that non-carriers experienced the most significant impairment of anti-platelet effect of clopidogrel after concomitant use of PPIs. This impairment was closely related to the metabolic dependence on CYP2C19 of PPI. CONCLUSIONS:Our study indicated that non-carriers of reduced-function CYP2C19 alleles are most susceptible to impairment of the anti-platelet effect of clopidogrel after concomitant PPI use. Individual subjects are not equally affected, and PPIs are not equally involved. However, large-scale randomized clinical trials are needed to evaluate the clinical outcome. KEY WORDS:Clopidogrel • CYP2C19 polymorphism • Platelet aggregation • Proton pump inhibitors • TEG • VASP.

SUBMITTER: Lee JK 

PROVIDER: S-EPMC4816920 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC3352012 | BioStudies
2018-01-01 | S-EPMC6714622 | BioStudies
2017-01-01 | S-EPMC5260476 | BioStudies
2015-01-01 | S-EPMC4717987 | BioStudies
2016-01-01 | S-EPMC4699636 | BioStudies
2013-01-01 | S-EPMC6649507 | BioStudies
2019-01-01 | S-EPMC6739775 | BioStudies
2016-01-01 | S-EPMC4826890 | BioStudies
2020-01-01 | S-EPMC7392938 | BioStudies
2012-01-01 | S-EPMC3304338 | BioStudies